Spiruchostatin A and B, novel histone deacetylase inhibitors, induce apoptosis through reactive oxygen species-mitochondria pathway in human lymphoma U937 cells.

[1]  B. Conley,et al.  Histone Deacetylation , 2020, Drugs in R&D.

[2]  Qing‐Li Zhao,et al.  Effects of SOD/catalase mimetic platinum nanoparticles on radiation-induced apoptosis in human lymphoma U937 cells , 2014, Apoptosis.

[3]  Y. Tabuchi,et al.  Inhibition of DNA-dependent protein kinase promotes ultrasound-induced cell death including apoptosis in human leukemia cells. , 2012, Cancer letters.

[4]  T. Katoh,et al.  Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatin B towards susceptible NALM-6 human B cell leukemia cells. , 2011, International journal of oncology.

[5]  Claudia P. Miller,et al.  Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors , 2011, Journal of biomedicine & biotechnology.

[6]  Y. Kagawa,et al.  Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide , 2010, Cancer science.

[7]  Qing‐Li Zhao,et al.  Role of fatty acid chain length on the induction of apoptosis by newly synthesized catechin derivatives. , 2010, Chemico-biological interactions.

[8]  Minoru Yoshida,et al.  Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity. , 2009, Chemistry.

[9]  W-S Xu,et al.  Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.

[10]  G. Giaccone,et al.  Histone deacetylase inhibitors in cancer therapy , 2008, Current opinion in oncology.

[11]  Jorge A. Almenara,et al.  Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions , 2008, Molecular Cancer Therapeutics.

[12]  K. Shin‐ya,et al.  Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A. , 2008, Biochemical pharmacology.

[13]  Qing‐Li Zhao,et al.  Rapid and transient intracellular oxidative stress due to novel macrosphelides trigger apoptosis via Fas/caspase-8-dependent pathway in human lymphoma U937 cells. , 2007, Chemico-biological interactions.

[14]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[15]  Xianglin Shi,et al.  Actions of a Histone Deacetylase Inhibitor NSC3852 (5-Nitroso-8-quinolinol) Link Reactive Oxygen Species to Cell Differentiation and Apoptosis in MCF-7 Human Mammary Tumor Cells , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  P. Atadja,et al.  The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. , 2006, Molecular pharmacology.

[17]  S. Grant,et al.  Histone deacetylase inhibitors: insights into mechanisms of lethality , 2005, Expert opinion on therapeutic targets.

[18]  Y. Hiraku,et al.  Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. , 2005, Life sciences.

[19]  Zheng-Guo Cui,et al.  Effects of antioxidants on X-ray- or hyperthermia-induced apoptosis in human lymphoma U937 cells , 2004, Apoptosis.

[20]  Yasuaki Yamada,et al.  The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. , 2004, Molecular cancer therapeutics.

[21]  J. Toguchida,et al.  FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells , 2003, Oncogene.

[22]  J. Trapani,et al.  Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. , 2003, Cancer research.

[23]  M. Grever,et al.  Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. , 2003, Blood.

[24]  Jorge A. Almenara,et al.  The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. , 2003, Cancer research.

[25]  Ricky W Johnstone,et al.  Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? , 2003, Cancer cell.

[26]  Y. Urano,et al.  Development of Novel Fluorescence Probes That Can Reliably Detect Reactive Oxygen Species and Distinguish Specific Species* 210 , 2003, The Journal of Biological Chemistry.

[27]  S. Oikawa,et al.  Mechanism of Apoptosis Induced by a New Topoisomerase Inhibitor through the Generation of Hydrogen Peroxide* , 2002, The Journal of Biological Chemistry.

[28]  D. Bernhard,et al.  The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Heinzel,et al.  Histone deacetylase as a therapeutic target , 2001, Trends in Endocrinology & Metabolism.

[30]  A. Harel-Bellan,et al.  Histone acetylation and disease , 2001, Cellular and Molecular Life Sciences CMLS.

[31]  K. Shin‐ya,et al.  Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. , 2001 .

[32]  P. Pelicci,et al.  Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. , 2001, Cancer research.

[33]  Qing‐Li Zhao,et al.  Apoptosis Induced by Cadmium in Human Lymphoma U937 Cells through Ca2+-calpain and Caspase-Mitochondria- dependent Pathways* , 2000, The Journal of Biological Chemistry.

[34]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[35]  W. D. Cress,et al.  Histone deacetylases, transcriptional control, and cancer , 2000, Journal of cellular physiology.

[36]  Shigeomi Shimizu,et al.  Bcl‐2 family: Life‐or‐death switch , 2000, FEBS letters.

[37]  T. Kouzarides.  Histone acetylases and deacetylases in cell proliferation. , 1999, Current opinion in genetics & development.

[38]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[39]  S. Schreiber,et al.  Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. , 1997, Current opinion in chemical biology.

[40]  T. Cotter,et al.  Role of peroxide and superoxide anion during tumour cell apoptosis , 1997, FEBS letters.

[41]  J. Cohen,et al.  Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. , 1987, Journal of immunology.

[42]  S. Gibson,et al.  Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells , 2013, Apoptosis.